Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

AIM: To evaluates the effectiveness and safety of the first generation, NS3/4A protease inhibitors (PIs) in clinical practice against chronic C virus, especially in patients with advanced fibrosis. METHODS: Prospective study and non-experimental analysis of a multicentre cohort of 38 Spanish hospita...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Gastroenterol
Hauptverfasser: Salmerón, Javier, Vinaixa, Carmen, Berenguer, Rubén, Pascasio, Juan Manuel, Sánchez Ruano, Juan José, Serra, Miguel Ángel, Gila, Ana, Diago, Moisés, Romero-Gómez, Manuel, Navarro, José María, Testillano, Milagros, Fernández, Conrado, Espinosa, Dolores, Carmona, Isabel, Pons, José Antonio, Jorquera, Francisco, Rodriguez, Francisco Javier, Pérez, Ramón, Montero, José Luis, Granados, Rafael, Fernández, Miguel, Martín, Ana Belén, Muñoz de Rueda, Paloma, Quiles, Rosa
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Inc 2015
Schlagworte:
Prospective Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533049/
https://ncbi.nlm.nih.gov/pubmed/26290644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i30.9163
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge